The project aims to qualify a battery of tasks measuring different reward processing domains to support drug development. By conducting early-stage development and validation of reward processing tasks, the ultimate goal is to develop paradigms that are used in experimental medicine and/or larger clinical trials.

The ANAPNEO project is directly funded by Smartcardia, which is a Swiss medical device company with focus on clinical quality data and validation ( Its aim is to scientifically evaluate and validate a smart, wearable device used to extract multi-faceted daily and sleep data for precision sleep medicine and prevention of sleep disorders.

Subscribe to RSS - Private Funding